NSTG - ナノストリング・テクノロジ―ズ (NanoString Technologies Inc.) ナノストリング・テクノロジ―ズ

 NSTGのチャート


 NSTGの企業情報

symbol NSTG
会社名 NanoString Technologies Inc (ナノストリング・テクノロジ―ズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ナノストリング・テクノロジーズ(NanoString Technologies Inc.)は微量の組織から実用的なゲノム情報を科学的・臨床的に解き明かす製品の設計・製作・販売に従事する。同社は、単一の組織サンプルから数百の遺伝子およびタンパク質の活性を同時にプロファイリングするための機器、消耗品およびサービスの開発、製造および販売に従事する。同社のnCounter Analysis Systemはバーコード技術を使用して数百分子の分子を直接プロファイリングする自動化されたマルチアプリケーション、デジタル検出およびカウントシステムである。同社は基本的な生物学およびがんのような疾患の分子基盤、および診断用の臨床検査機関および医療センターに使用するためにシステムおよび関連消耗品を学術、政府および生物医薬品研究所の研究者に販売する。   ナノストリング・テクノロジ―ズは、米国の医療機器メ―カ―。ダイレクトデジタル計測遺伝子解析システム「nCounter」を開発、製造、販売する。バ―コ―ド技術により、最大800遺伝子を1チュ―ブで同時カウントする「nCounter」と関連する消耗品を学術、政府の研究者や臨床検査室、医療センタ―へ販売する。   NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 4,000 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx® Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.
本社所在地 530 Fairview Avenue North Seattle WA 98109 USA
代表者氏名 William D. Young ウィリアム・D・ヤング
代表者役職名 Independent Chairman of the Board
電話番号 +1 206-378-6266
設立年月日 37773
市場名 NASDAQ National Market System
ipoyear 2013年
従業員数 467人
url www.nanostring.com
nasdaq_url https://www.nasdaq.com/symbol/nstg
adr_tso
EBITDA EBITDA(百万ドル) -50.37300
終値(lastsale) 15.61
時価総額(marketcap) 464987745.32
時価総額 時価総額(百万ドル) 471.83890
売上高 売上高(百万ドル) 110.33300
企業価値(EV) 企業価値(EV)(百万ドル) 470.87190
当期純利益 当期純利益(百万ドル) -22.26800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 NanoString Technologies Inc revenues decreased 9% to $48.1M. Net loss increased 70% to $39.8M. Revenues reflect North America segment decrease of 17% to $32.8M Asia Pacific segment decrease of 10% to $3.1M. Higher net loss reflects Research and development increase of 30% to $28.4M (expense) Selling general and administrative increase of 11% to $40.1M (expense).

 NSTGのテクニカル分析


 NSTGのニュース

   NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference  2021/03/01 15:06:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString announces highlights of 2021 Advances in Genome Biology and Technology conference.
   NanoString Technologies Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2021/03/01 14:10:00 Stock Market Daily
NanoString Technologies announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   A Preview Of NanoString Technologies's Earnings  2021/02/26 10:06:00 Benzinga
NanoString Technologies (NASDAQ:NSTG) unveils its next round of earnings this Monday, March 01. Get prepared with Benzinga's ultimate preview for …
   NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference  2021/02/24 11:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString to present at the 41st annual Cowen healthcare conference.
   NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021  2021/02/22 11:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString announces launch of GeoMx DSP Whole Transcriptome Atlas.
   NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference  2021/03/01 15:06:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString announces highlights of 2021 Advances in Genome Biology and Technology conference.
   NanoString Technologies Earnings Report: Here’s what to expect from Stock market Insights & financial analysis  2021/03/01 14:10:00 Stock Market Daily
NanoString Technologies announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   A Preview Of NanoString Technologies's Earnings  2021/02/26 10:06:00 Benzinga
NanoString Technologies (NASDAQ:NSTG) unveils its next round of earnings this Monday, March 01. Get prepared with Benzinga's ultimate preview for …
   NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference  2021/02/24 11:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString to present at the 41st annual Cowen healthcare conference.
   NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021  2021/02/22 11:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString announces launch of GeoMx DSP Whole Transcriptome Atlas.
   Nature Medicine Publishes First Study Utilizing NanoString’s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas  2021/02/09 11:00:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal Nature Medicine that used NanoString’s GeoMx® Digital Spatial Profiler (DSP) and the new Whole Transcriptome Atlas (WTA) to profile sarcoma tissue. The research was led by a team from the Broad Institute in Cambridge, Massachusetts. The paper, entitled “Opposing immune and genetic mecha
   Insider Selling: NanoString Technologies, Inc. (NASDAQ:NSTG) Director Sells 2,500 Shares of Stock  2021/01/13 22:48:44 Watchlist News
NanoString Technologies, Inc. (NASDAQ:NSTG) Director Kirk Malloy sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, January 11th. The shares were sold at an average price of $66.53, for a total value of $166,325.00. Following the transaction, the director now directly owns 1,990 shares of the company’s stock, valued at […]
   NanoString to Present at the 39th Annual J.P. Morgan Healthcare Conference  2021/01/04 21:01:00 Business Wire
SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the JP Morgan Healthcare conference.
   Insider Selling: NanoString Technologies, Inc. (NASDAQ:NSTG) Director Sells $606,877.92 in Stock  2020/12/12 10:10:44 Watchlist News
NanoString Technologies, Inc. (NASDAQ:NSTG) Director Gregory Norden sold 10,406 shares of NanoString Technologies stock in a transaction dated Monday, December 7th. The stock was sold at an average price of $58.32, for a total value of $606,877.92. Following the transaction, the director now owns 12,296 shares in the company, valued at $717,102.72. The transaction was […]
   Digital Genome Market Business Insights 2020 : Umbel, BiogeniQ, GenomeMe, NanoString, Illumina and Others  2020/12/03 17:08:58 OpenPR
Global Digital Genome Market Research Report, by Product (Sequencing Services, Instruments), Application (Diagnostics, Agriculture & Animal Research), End-User (Research Centers and Government Institutes, Academic Institutions) – Global Forecast Till 2027 Digital Genome Market Overview: The penetration of advanced technology in the

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ナノストリング・テクノロジ―ズ NSTG NanoString Technologies Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)